Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hexopal

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryThe peripheral vasospastic symptoms associated with Raynaud's disease continue to be an unsolved clinical problem. Hexopal… Expand
  • figure 1
  • figure 2
  • table II
  • table I
1988
1981
1981
The objective assessment of thermography was used to quantify the response to cold stress in the hands of sufferers from Raynaud… Expand
  • table 1
  • table 2
  • figure I
  • table 3
  • figure 2
1979
1979
  • M. Aylward
  • The Journal of international medical research
  • 1979
  • Corpus ID: 37980700
Twenty female patients with primary Raynaud's phenomenon were included in a 9-month open assessment of Hexopal® tablets… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
1979
1979
  • G. Holti
  • The Journal of international medical research
  • 1979
  • Corpus ID: 37586260
The vaso-active effects of inositol nicotinate (Hexopal®) were investigated in thirty patients with primary and secondary Raynaud… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
1977
1977
  • E. Ring, P. Bacon
  • The Journal of international medical research
  • 1977
  • Corpus ID: 27360518
The basal temperature of the hands has been measured by quantitative thermography in a group of normal controls and rheumatoid… Expand
  • figure 1
  • figure 2
  • figure 3
1975
1975
A double-blind comparison of Bradilan (tetranicotinoylfructose) tablets 250 mg and Hexopal (inositol nicotinate) 500 mg tablets… Expand
  • table 1
1972
1972
It is shown that Meso-Inositol Hexanicotinate (MIHN; Hexopal) inhibits experimentally induced oedema of the paw in rats and that… Expand